Life expectancy among antiretroviral-treated HIV-positive people in the United States and Canada rose substantially during the 2000s, approaching life expectancy estimates in the general population [1]. But certain subgroups, including nonwhites and people who start antiretroviral therapy (ART) at a CD4 count below 350, still greatly lag the general population in life expectancy, according to this North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) analysis.
Read more ...
Read more ...
RSS Feed